Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
18.44
-0.30 (-1.60%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Damora Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $40 | Buy | Maintains | $40 | +116.92% | Sep 29, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $40 → $60 | Buy | Maintains | $40 → $60 | +225.38% | Sep 25, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $45 | Buy | Maintains | $45 | +144.03% | Sep 18, 2026 |
| Jefferies | Jefferies | Buy Maintains $50 | Buy | Maintains | $50 | +171.15% | Aug 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $40 | Buy | Maintains | $40 | +116.92% | Aug 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 | Buy | Reiterates | $45 | +144.03% | Aug 11, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 11, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $55 → $51 | Buy | Maintains | $55 → $51 | +176.57% | May 15, 2026 |